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doi:10.1Objective:During the last 2 decades, we have applied a repair-oriented surgical approach to patients with active
mitral valve endocarditis. We retrospectively analyzed the long-term outcomes with this repair-oriented
approach.
Method: Between 1991 and 2010, 137 patients underwent operation for active mitral valve endocarditis; of
these, 109 patients (80%) had mitral valve repair and represent the study cohort. Repair techniques without
patch extension (no-patch techniques) include triangular or quadrangular resection (n ¼ 49), sliding plasty
(n ¼ 24), neochordae (n ¼ 18), chordal transfer (n ¼ 12), and others (n ¼ 5). Repair techniques using patch
extension (patch techniques) included pericardium (n ¼ 42), tricuspid autograft (n ¼ 8), flip-over technique
(n ¼ 7), and partial mitral valve homograft (n ¼ 5). Patches were used in 67 patients (61%). Ring annuloplasty
was performed in 60 patients, and a pericardial band was used in 13 patients. Clinical and echocardiographic
follow-up were performed. Median follow-up was 48 months.
Results:Hospital mortality was 16%. At 8 years, overall survival was 62% 10%with no differences between
patients with or without patch repair (P ¼ .5). Freedom from mitral valve repair failure was 81%  14% in
patients with patch repair and 90%  10% in patients without patch repair (P ¼ .09). The rate of thromboem-
bolic or bleeding event was 1% per patient-year, and the rate of endocarditis recurrence was 0.3% per patient-
year. Univariable predictors of mortality were age more than 70 years (P< .0001), perivalvular abscess
(P ¼ .002), diabetes mellitus (P ¼ .0002), and renal failure (P ¼ .04). Predictors of repair failure were renal
failure (P ¼ .035) and perivalvular abscess (P ¼ .033).
Conclusions: In active mitral valve endocarditis, a repair-oriented surgical approach achieves a reparability
rate of 80%with acceptable morbidity and good long-term results. The use of patch techniques offers a durabil-
ity rate that approximates the rate obtained with the no-patch techniques. (J Thorac Cardiovasc Surg
2012;143:S91-5)In native valve infective endocarditis (IE), the mitral valve
(MV) is the most frequently affected (40%–50% of the
cases).1 There are several conceptual advantages of valve
repair versus replacement in the setting of mitral IE. Multi-
ple authors have advocated MV repair for IE since Dreyfus
and colleagues2 published their initial series in 1990. In
a meta-analysis, Feringa and colleagues3 showed that MV
repair in the setting of IE was associated with good clinical
in-hospital and long-term results. However, the reported
rate of MV repair was only 40% for this indication, in com-
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The Journal of Thoracic and Carlower repair rate for IE is likely related to the type of lesions
encountered and patient comorbidities. Large vegetations,
multiple lesions, and annular abscess are all challenging
to repair, and the classic techniques used in degenerative
disease may be inappropriate in such situations. Moreover,
patients with active IE commonly present in unstable condi-
tions, which may influence the surgeon to perform an expe-
ditious replacement instead of a difficult repair.
During the last 2 decades, our surgical approach toward
active IE has evolved as predominantly repair oriented.
This was characterized by an early intervention, a radical
resection of the lesion, and an aggressive attitude toward
valve repair using biological patch material to extend the
spectrum of patients eligible to undergo valve repair.
The purpose of the current study was to analyze the long-
term results achieved with this approach. In addition, we ex-
amined the durability of patch repair techniques compared
with more classic repair techniques to determine if their
use was justified.
PATIENTS AND METHODS
Patient Selection
Only patients undergoing operation during the active phase of native
MV endocarditis were included. Active IE was defined as the period of
time from diagnosis to completion of antibiotic therapy. Any patientsdiovascular Surgery c Volume 143, Number 4S S91
Endocarditis de Kerchove et alS9Abbreviations and Acronyms
IE ¼ infective endocarditis
MR ¼ mitral regurgitation
MV ¼ mitral valveundergoing operation after completion of antibiotic therapy (delayed sur-
gery) were excluded. From 1991 to 2010, 137 patients underwent operation
for active MV endocarditis at the Cliniques Universitaires Saint-Luc. Of
these patients, 109 (80%) had MV repair and comprise the study cohort.
Preoperative patient characteristics, intraoperative data, and immediate
postoperative course were obtained from hospital records and operative
notes (Table 1). This study was approved by the institutional ethics review
board, and the need for written informed consent was waived for this study.
The first half of this patient cohort has been described by the authors.4
Timing of Surgery
Indications for surgery were evaluated by a multidisciplinary team and
included MV dysfunction with heart failure, IE caused by fungal or other
highly resistant organism, annular abscess, recurrent emboli, persistent
vegetation or fever despite appropriate antibiotics therapy, and mobile veg-
etation larger than 10 mm.5 Timing for surgery depended on the indication
and severity of clinical and echocardiographic findings. Early surgery was
favored to preserve tissues from further destruction and to increase possi-
bilities of MV repair. The presence of stroke did not contraindicate early
surgery. However, surgery was delayed in case of stroke with severe neuro-
logic dysfunction (eg, unconsciousness) or with hemorrhagic complica-
tion. With increasing experience in MV repair for active IE, we
progressively expanded the indication for ‘‘early’’ surgery to include pa-
tients presenting with severe mitral regurgitation (MR) but no other com-
plication. In those patients, surgery was performed electively before
completion of antibiotic therapy.
As previously reported, the median delay between diagnosis and sur-
gery has decreased since the early period of the study.4 In the last 5 years,
the median delay was 9 days and 75% of the patients underwent operation
within 2 weeks after diagnosis.
Surgical Techniques
All patients underwent operation via a median sternotomy. TheMVwas
exposed via a left atriotomy. A thorough valve analysis was performed to
identify IE lesion and the presence of concomitant degenerative or rheu-
matic lesions. Vegetations were resected with caution to preserve nonin-
fected tissues to maximize the possibility of valve repair. The leaflet free
margin and normal native chordae were preserved whenever possible.
The repair techniques are listed in Table 1. Posterior and commissural
valve defects were generally primarily closed using triangular or quadran-
gular resection and sliding techniques. In case of a large defect, limited
amount of native tissues, or resection of annular abscess or calcification,
the posterior leaflet and commissures were repaired with patch techniques.
Anterior valve defects were generally repaired using patch techniques to
avoid reduction of its surface.
A variety of patches were used for leaflet and annulus repair, each type
having a specific indication. Autologous and bovine pericardium were the
most frequently used patches. Untreated autologous pericardium was typ-
ically used to repair leaflet perforation. Glutaraldehyde-treated autologous
pericardium and bovine pericardium, both offering the advantage of easier
manipulation, were used for more complex repair, such as free margin de-
struction repair. In those cases, the neo free margin was suspended with na-
tive chordae transfer or artificial chordae. Bovine pericardium was used in
cases in which autologous pericardium was not readily available, such as
reoperative surgery. After resection of the posterior annulus for abscess2 The Journal of Thoracic and Cardiovascular Surgor calcification, atrioventricular junction was repaired by a Teflon-
reinforced U-stitch or a bovine pericardial patch covering the area of resec-
tion.When necessary, this pericardial patch was folded on its atrial side and
used to reinsert and extend the posterior leaflet. Bovine pericardium was
also used to repair the mitral-aortic continuity after abscess resection.
Three other types of patch technique were used for specific lesions. The
tricuspid valve autograft patch was used to repair large commissural de-
fects. The original technique was modified by adding 2 artificial chordae
on the tricuspid autograft free margin to partially relieve the tension on
the tricuspid papillary muscle suture.6 The flip-over technique (ie, transfer
of P2 to A2) was used to repair a defect of the anterior leaflet A2 segment.
Finally, parts of theMV homograft have been used to reconstruct large pos-
terior valve defects or to repair the mitral-aortic continuity. For posterior
valve reconstruction, a posterior MV homograft was inserted by first im-
planting its anterior and posterior papillary muscle onto the corresponding
native papillary muscle and then suturing the leaflet tissue in place. Com-
missures were closed by a few millimeters to initiate coaptation. After re-
section of the mitral-aortic continuity due to an abscess complicating aortic
valve endocarditis, the aortic valvewas replacedwith an aortic valve homo-
graft. The mitral-aortic continuity was reconstructed using the anterior mi-
tral leaflet of the aortic valve homograft. The anterior mitral homograft
valve was sutured with a running 4-0 polypropylene suture to the base or
body of the native anterior MV.
In addition to repair of the IE lesion, any degenerative rheumatic lesion
was addressed with resection techniques, commissurotomy, chordal trans-
fer, or artificial chordae. A prosthetic ring or pericardial band annuloplasty
was used in case of annulus dilatation to increase valve coaptation and sta-
bilize the repair. Intraoperative transesophageal echocardiography was per-
formed in all patients.
Postoperative Management
Antibiotic therapy started preoperatively was continued postoperatively
for 4 to 6 weeks. Anticoagulation for 2 months was indicated in patients
receiving prosthetic ring annuloplasty.
Follow-up
Clinical follow-up was conducted by outpatient visits or telephone
follow-up by a research nurse. Information on survival status, valve-
related complications, and cardiovascular symptoms was obtained. Trans-
thoracic echocardiography was obtained in all patients predischarge and at
regular intervals during follow-up. The closing interval for the study was
between November 2010 and January 2011. Clinical and echocardio-
graphic follow-ups were 99% and 86% complete, respectively. Median
follow-up was 65 months (interquartile range, 24–114 months).
Statistical Analyses
Statistical analyses were performed using SAS v. 9.1 (SAS Institute, Inc,
Cary, NC). Continuous data are presented as mean standard deviation or
median (interquartile range) for nonparametric data. Failure time data on
survival, MV reoperation, repair failure (defined as MV reoperation, MR
> 3þ, MV stenosis with mean gradient>10 mm Hg), and valve-related
events are presented using Kaplan–Meier curves. Patients with and without
patch repair techniques were compared for the different long-term out-
comes using log-rank testing. Univariable analysis using log-rank test
was performed to identify predictors of long-term mortality and repair
failure.RESULTS
Early Outcomes
Hospital mortality was 16% (n ¼ 17). Causes of death
were congestive heart failure (n ¼ 6), respiratory failure
(n ¼ 3), neurologic (n ¼ 3), sepsis (n ¼ 2), cardiac arrestery c April 2012
TABLE 1. Preoperative patient characteristics and intraoperative
data
Preoperative patient characteristics N ¼ 109 (%)
Age (mean  SD, range) 59  11 (19–85)
Male gender 74 (68)
History of cardiac surgery 18 (17)
Diabetes mellitus 19 (17)
Renal failure* 19 (17)
Preoperative hemodialysis 7 (6)
Septic emboli 35 (32)
Cerebrovascular emboli 21 (19)
NYHA  III 38 (35)
Cardiogenic shock 16 (15)
Uncontrolled/persistent sepsis 19 (17)
MR
Grade 1 13 (12)
Grade 2 26 (24)
Grade  3 70 (64)
Vegetation 89 (82)
Abscess and perivalvular extensiony 31 (28)
Multiple valve endocarditisz 26 (24)
Bacteriology
Streptococcus species 41 (38)
Staphylococcus species 31 (28)
Other species 24 (22)
Negative cultures 13 (12)
Operative findings on the MV
Posterior leaflet lesion 39 (36)
Anterior leaflet lesion 19 (17)
Bileaflet lesion 28 (26)
Posterolateral commissure lesion 16 (15)
Anteromedial commissure lesion 7 (6)
Abscess and perivalvular extension 24 (22)
MV disease other than infectionx 49 (45)
Operative techniques
MV repair techniques (without patch)k
Quadrangular/triangular resection 49 (45)
Resectionþsliding plasty 24 (22)
Artificial chordae (Gore-Tex CV5; WL
Gore & Associates, Inc, Flagstaff, Ariz)
21 (19)
Native chordae tendineae transfer 12 (11)
Commissurotomy 3 (3)
Papillary muscle plication 2 (2)
MV repair with patch techniques 67 (61)
Autologous or bovine pericardial patch 51 (47)
Tricuspid valve autograft 8 (7)
Flip-over technique 7 (6)
Partial MV homograft 5 (5)
MV annuloplasty 73 (67)
Prosthetic ring{ 60 (55)
Ring size
26 4 (4)
28 10 (9)
30 18 (17)
32 17 (16)
34 5 (5)
36 3 (3)
(Continued)
TABLE 1. Continued
Preoperative patient characteristics N ¼ 109 (%)
Pericardial band 13 (12)
Aortic crossclamp time (min; mean  SD) 95  37
Cardiopulmonary bypass time (min; mean  SD) 122  46
Associated procedure# 46 (42)
NYHA, New York Heart Association; SD, standard deviation; MR, mitral regurgita-
tion. *Serum creatinine serum level>2 mg/dL. yMitral or aortic valve abscess.
zIncludes aortic valve (n¼ 23) or tricuspid valve (n¼ 2). xIncludes myxomatous dis-
ease (n ¼ 19), calcification (n ¼ 11), Barlow disease (n ¼ 7), rheumatic disease (n ¼
6), previous MV repair (5), and congenital disease (n ¼ 1). kMore than 1 technique
was generally performed in a single patient, and no-patch techniques may coexist
with patch techniques. {Includes rigid ring (n ¼ 54) (Carpentier Edwards Physio
ring, Edwards Lifesciences Corp, Irvine, Calif, n ¼ 43; CG Future ring, Medtronic
Inc, Minneapolis, Minn, n ¼ 4; Saddle ring, St Jude Medical Inc, St Paul, Minn, n
¼ 4; unknown brand, n ¼ 3) and supple ring (Duran AnCore ring (Medtronic Inc,
n ¼ 6). #Includes aortic valve replacement or repair (n ¼ 17), aortic annulus repair
with patch and aortic valve replacement (n ¼ 9), tricuspid valve repair (n ¼ 12),
and coronary artery bypass grafting (n ¼ 12).
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for bleeding occurred in 11% of patients (n ¼ 12), a per-
manent pacemaker was implanted in 3.7% of patients
(n ¼ 4), reoperation for superficial and deep sternal infec-
tion was performed in 2.8% of patients (n ¼ 3), and a new
cerebrovascular event occurred in 4.6% of patients (n ¼
5). MV reoperation was necessary in 5 patients (4.6%)
(4 replacements, 1 re-repair). The mechanisms of repair
failure were suture dehiscence in 4 patients and systolic
anterior motion in 1 patient. Suture dehiscence occurred af-
ter pericardial patch repair (n ¼ 2), quadrangular resection
(n ¼ 1), and tricuspid autograft patch repair (n ¼ 1). After
this last case (the first of our tricuspid autograft series), arti-
ficial chordae have systematically been used to relieve ten-
sion of tricuspid papillary muscle suture. Early MV
reoperation occurred in 6% of patients after patch repair
and in 2.4% of patients after no-patch repair (P ¼ .7). In
1 patient, the repair failure (patch dehiscence) was related
to an uncontrolled Staphylococcus aureus sepsis leading to
mediastinitis and recurrent endocarditis on postoperative
day 6.
Late Outcomes
At 8 years, overall survival was 62%  10%. Overall
survival was similar in patients with and without patch re-
pair (P ¼ .5) (Figure 1, A). Freedom from late cardiac
death was 85%  10% at 8 years. During the follow-up
period, 6 patients underwent MV reoperation for recurrent
MR; of these, 3 had MV replacement and 3 had MV re-
repair. At 8 years, freedom from MV reoperation was
89%  8% and freedom from MV replacement was
92%  8%. Freedom from MV reoperation was not sig-
nificantly different between patients with or without patch
repair (88%  10% vs 90%  10%; P ¼ .2; Figure 1, B);
however, freedom from MV replacement was significantly
lower in patients with patch repair (87%  10% vs
100%, P ¼ .03). At last echocardiographic follow-up,diovascular Surgery c Volume 143, Number 4S S93
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FIGURE 1. Kaplan–Meier actuarial survival curves comparing patients with or without patch repair. A, Overall survival including hospital mortality (P¼ .5).
B, Freedom from MV reoperation (P ¼ .2). C, Freedom from MV repair failure (P ¼ .09).
Endocarditis de Kerchove et al1 patient had severe MR and 2 patients had a mean MV
gradient greater than 10 mm Hg. Freedom from MV repair
failure at 8 years was 84%  10% with a nonsignificant
trend in favor of the patients without patch repair (81% 
14% vs 90%  10%; P ¼ .09) (Figure 1, C). In patients
with patch repair, freedom from MV repair failure was
higher in leaflet perforation repair than in free margin re-
pair or MVannulus repair (94% vs 72% vs 84%, P ¼ .5).
Recurrent IE occurred in 1 patient with patch repair. At 8
years, freedom from endocarditis recurrence was 99% 
2%. The linearized rate of endocarditis recurrence
was 0.3% per patient-year. A thromboembolic or bleeding
event occurred in 6 patients (4 strokes, 2 bleeding). At 8
years, freedom from thromboembolic or bleeding was
90%  8% with no significant difference between
patients with and without patch repair (P ¼ .8). The line-
arized rate of thromboembolic or bleeding event was 1%
per patient-year. At last follow-up contact, all patients
were in New York Heart Association class I (83%) or
II (17%).
Univariable Predictors of Mortality and Repair
Failure
In the univariate analysis, the most significant predictors
of long-term mortality were advanced age (>70 years) (P<
.0001), perivalvular extension (ie, abscess or fistula) (P ¼
.002), diabetes mellitus (P ¼ .0002), and renal failure
(plasma creatinine level<2 mg/dL) (P ¼ .04). In terms ofS94 The Journal of Thoracic and Cardiovascular Surgpredictors of repair failure, only renal failure (P ¼ .035)
and perivalvular extension (P ¼ .033) were significant.
Patch use and preexisting calcified or rheumatic valve dis-
ease showed nonsignificant trends toward repair failure
(P ¼ .09 for both).
DISCUSSION
In this 2-decade retrospective study of MV repair for
active IE, we showed that the use of a repair-oriented sur-
gical approach achieves a repair rate of 80% with accept-
able morbidity and good long-term results. In 60% of the
cases, patch repairs were used to restore MV function,
and the durability of those techniques approximates
the durability obtained with no-patch reconstructive
techniques.
Our specific approach to active IE has apparently not re-
duced mortality in comparison with a less aggressive recon-
structive surgical approach.7,8 This findingmay be explained
by the fact that in IE, the potential survival benefit conferred
by MV repair is negated by disease-related factors, such as
advanced age, associated comorbidities, and perivalvular ex-
tension, which are all strong predictors of mortality. How-
ever, as already reported by Feringa and colleagues3 in
a meta-analysis comparing MV repair with replacement in
IE, we confirm the benefit of MV repair in terms of low rates
of cerebrovascular event and recurrent IE.
With respect to the durability of MV repairs, our results
show that for patients undergoing repair with the no-patchery c April 2012
de Kerchove et al Endocarditistechniques classically used in degenerative MV disease, the
durability is similar to the long-term results reported in MV
repair for degenerative disease.9,10 The use of a patch for
leaflet extension or annulus repair was associated with
a somewhat higher long-term failure rate in comparison
with the no-patch techniques, but the difference did not
reach statistical significance. Reasons for the relatively
good outcomes of patch repair techniques may be that we
used a patch technique for localized repair only, respecting
the native tissue asmuch as possible, and that we adapted the
type of patch to the lesion as described in our surgical tech-
niques. Of note, patch-related durability is also influenced
by the type of patch and theway the patch is used. For a peri-
cardial patch, better durability is suggested in patients in
whom it was used to treat leaflet perforation. Therefore,
leaflet free margin, even a thin band, should be preserved
whenever possible. The autologous transfer from posterior
to anterior leaflet, the flip-over technique, has shown no fail-
ure; a wider use of this technique may be an option to im-
prove the results of anterior free margin repair.
Suture dehiscence observed in early failures is likely re-
lated to excessive tension on the sutured tissues. There are 2
potential technical solutions to this problem: to reduce the
tension on the suture and to make the suture stronger. For
example, a more aggressive annular reduction in addition
to quadrangular resection will reduce tension on leaflet ap-
proximation. Additional artificial chordae or chordae trans-
fer will reduce tension on a free margin patch or a tricuspid
autograft papillary muscle suture. On the other hand, rein-
forcement of the suture itself can be done by suturing in
healthy tissues (ie, non-inflammatory tissues), by taking
more tissue in the suture (ie, larger bites), or by adding sin-
gle stitches over a running suture.The Journal of Thoracic and CarCONCLUSIONS
In active MV endocarditis, a repair-oriented surgical ap-
proach, including early surgery and liberal use of biological
patch techniques, achieves a repair rate of 80%with accept-
able morbidity and good long-term results. Patch tech-
niques were used in 60% of the cases and offer
a durability rate that approximates the rate obtained with
no-patch reconstructive techniques.References
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